참고문헌
- Rivera-Espinoza Y, Muriel P. Pharmacological actions of curcumin in liver diseases or damage. Liver Int 2009; 29: 1457-1466. https://doi.org/10.1111/j.1478-3231.2009.02086.x
- Basnet P, Skalko-Basnet N. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 2011; 16: 4567-4598. https://doi.org/10.3390/molecules16064567
- Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 2008; 75: 787-809. https://doi.org/10.1016/j.bcp.2007.08.016
- Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 2009; 30: 85-94. https://doi.org/10.1016/j.tips.2008.11.002
- Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med 2003; 9: 161-168. https://doi.org/10.1089/107555303321223035
- Burgos-Moron E, Calderon-Montano JM, Salvador J, Robles A, Lopez-Lazaro M. The dark side of curcumin. Int J Cancer 2010; 126: 1771-1775.
- Kapoor S. Curcumin and its emerging role in pain modulation and pain management. Korean J Pain 2012; 25: 202-203. https://doi.org/10.3344/kjp.2012.25.3.202
- Agarwal KA, Tripathi CD, Agarwal BB, Saluja S. Efficacy of turmeric (curcumin) in pain and postoperative fatigue after laparoscopic cholecystectomy: a double-blind, randomized placebo-controlled study. Surg Endosc 2011; 25: 3805-3810 https://doi.org/10.1007/s00464-011-1793-z
- Sharma S, Kulkarni SK, Agrewala JN, Chopra K. Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pharmacol 2006; 536: 256-261. https://doi.org/10.1016/j.ejphar.2006.03.006
- Zhao X, Xu Y, Zhao Q, Chen CR, Liu AM, Huang ZL. Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved. Neuropharmacology 2012; 62: 843-854. https://doi.org/10.1016/j.neuropharm.2011.08.050
- Tajik H, Tamaddonfard E, Hamzeh-Gooshchi N. The effect of curcumin (active substance of turmeric) on the acetic acidinduced visceral nociception in rats. Pak J Biol Sci 2008; 11: 312-314. https://doi.org/10.3923/pjbs.2008.312.314
- Yeon KY, Kim SA, Kim YH, Lee MK, Ahn DK, Kim HJ, et al. Curcumin produces an antihyperalgesic effect via antagonism of TRPV1. J Dent Res 2010; 89: 170-4. https://doi.org/10.1177/0022034509356169
- Mittal N, Joshi R, Hota D, Chakrabarti A. Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat. Phytother Res 2009; 23: 507-512. https://doi.org/10.1002/ptr.2662
- Leamy AW, Shukla P, McAlexander MA, Carr MJ, Ghatta S. Curcumin ((E,E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6- heptadiene-3,5-dione) activates and desensitizes the nociceptor ion channel TRPA1. Neurosci Lett 2011; 503: 157-162. https://doi.org/10.1016/j.neulet.2011.07.054
- Du X, Wang C, Zhang H. Activation of ATP-sensitive potassium channels antagonize nociceptive behavior and hyperexcitability of DRG neurons from rats. Mol Pain 2011; 7: 35. https://doi.org/10.1186/1744-8069-7-35
- Lazaro-Ibanez GG, Torres-Lopez JE, Granados-Soto V. Participation of the nitric oxide-cyclic GMP-ATP-sensitive K(+) channel pathway in the antinociceptive action of ketorolac. Eur J Pharmacol 2001; 426: 39-44. https://doi.org/10.1016/S0014-2999(01)01206-7
- Ortiz MI, Granados-Soto V, Castaneda-Hernandez G. The NO-cGMP-K+ channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin. Pharmacol Biochem Behav 2003; 76: 187-195. https://doi.org/10.1016/S0091-3057(03)00214-4
- Leon-Reyes MR, Castaneda-Hernandez G, Ortiz MI. Pharmacokinetics and pharmacodynamics of diclofenac in the presence and absence of glibenclamide in the rat. J Pharm Pharm Sci 2008; 11: 68-76.
- Ocana M, Del Pozo E, Barrios M, Robles LI, Baeyens JM. An ATP-dependent potassium channel blocker antagonizes morphine analgesia. Eur J Pharmacol 1990; 186: 377-378. https://doi.org/10.1016/0014-2999(90)90466-J
- Ocana M, Baeyens JM. Differential effects of K+ channel blockers on antinociception induced by alpha 2-adrenoceptor, GABAB and kappa-opioid receptor agonists. Br J Pharmacol 1993; 110: 1049-1054. https://doi.org/10.1111/j.1476-5381.1993.tb13919.x
- Robles LI, Barrios M, Del Pozo E, Dordal A, Baeyens JM. Effects of K+ channel blockers and openers on antinociception induced by agonists of 5-HT1A receptors. Eur J Pharmacol 1996; 295: 181-188. https://doi.org/10.1016/0014-2999(95)00643-5
- Kweon TD, Kim JY, Kwon IW, Choi JB, Lee YW. Participation of K(ATP) channels in the antinociceptive effect of pregabalin in rat formalin test. Korean J Pain 2011; 24: 131-136. https://doi.org/10.3344/kjp.2011.24.3.131
- Soares AC, Leite R, Tatsuo MA, Duarte ID. Activation of ATP-sensitive K(+) channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. Eur J Pharmacol 2000; 400: 67-71. https://doi.org/10.1016/S0014-2999(00)00355-1
- White RE, Lee AB, Shcherbatko AD, Lincoln TM, Schonbrunn A, Armstrong DL. Potassium channel stimulation by natriuretic peptides through cGMP-dependent dephosphorylation. Nature 1993; 361: 263-266. https://doi.org/10.1038/361263a0
- Ocana M, Barrios M, Baeyens JM. Cromakalim differentially enhances antinociception induced by agonists of alpha(2)- adrenoceptors, gamma-aminobutyric acid(B), mu and kappa opioid receptors. J Pharmacol Exp Ther 1996; 276: 1136-1142
- Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109-110. https://doi.org/10.1016/0304-3959(83)90201-4
- Jeong HJ, Lee SH, Cho SY, Lee CS, Jeong CW, Yoon MH, et al. Roles of serotonergic and adrenergic receptors in the antinociception of selective cyclooxygenase-2 inhibitor in the rat spinal cord. Korean J Pain 2011; 24: 179-184. https://doi.org/10.3344/kjp.2011.24.4.179
- Ortiz MI, Lozano-Cuenca J, Granados-Soto V, Castaneda- Hernandez G. Additive interaction between peripheral and central mechanisms involved in the antinociceptive effect of diclofenac in the formalin test in rats. Pharmacol Biochem Behav 2008; 91: 32-37. https://doi.org/10.1016/j.pbb.2008.06.008
- Lozano-Cuenca J, Castaneda-Hernandez G, Granados- Soto V. Peripheral and spinal mechanisms of antinociceptive action of lumiracoxib. Eur J Pharmacol 2005; 513: 81-91. https://doi.org/10.1016/j.ejphar.2005.02.049
- Ortiz MI, Ramirez-Montiel ML, Gonzalez-Garcia MP, Ponce- Monter HA, Castaneda-Hernandez G, Carino-Cortes R. The combination of naproxen and citral reduces nociception and gastric damage in rats. Arch Pharm Res 2010; 33: 1691-1697. https://doi.org/10.1007/s12272-010-1020-9
- Jimenez-Andrade JM, Ortiz MI, Perez-Urizar J, Aguirre- Banuelos P, Granados-Soto V, Castaneda-Hernandez G. Synergistic effects between codeine and diclofenac after local, spinal and systemic administration. Pharmacol Biochem Behav 2003; 76: 463-471. https://doi.org/10.1016/j.pbb.2003.09.001
- Gil-Flores M, Ortiz MI, Castaneda-Hernandez G, Chavez- Pina AE. Acemetacin antinociceptive mechanism is not related to NO or K+ channel pathways. Methods Find Exp Clin Pharmacol 2010; 32: 101-105.
- Ocana M, Cendan CM, Cobos EJ, Entrena JM, Baeyens JM. Potassium channels and pain: present realities and future opportunities. Eur J Pharmacol 2004; 500: 203-219. https://doi.org/10.1016/j.ejphar.2004.07.026
- Alves DP, Soares AC, Francischi JN, Castro MS, Perez AC, Duarte ID. Additive antinociceptive effect of the combination of diazoxide, an activator of ATP-sensitive K+ channels, and sodium nitroprusside and dibutyryl-cGMP. Eur J Pharmacol 2004; 489: 59-65. https://doi.org/10.1016/j.ejphar.2004.02.022
- Soares AC, Duarte ID. Dibutyryl-cyclic GMP induces peripheral antinociception via activation of ATP-sensitive K(+) channels in the rat PGE2-induced hyperalgesic paw. Br J Pharmacol 2001; 134: 127-131. https://doi.org/10.1038/sj.bjp.0704224
- Distrutti E, Sediari L, Mencarelli A, Renga B, Orlandi S, Antonelli E, et al. Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. J Pharmacol Exp Ther 2006; 316: 325-335.
- Han YK, Lee SH, Jeong HJ, Kim MS, Yoon MH, Kim WM. Analgesic effects of intrathecal curcumin in the rat formalin test. Korean J Pain 2012; 25: 1-6. https://doi.org/10.3344/kjp.2012.25.1.1
- Tsai YM, Chien CF, Lin LC, Tsai TH. Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. Int J Pharm 2011; 416: 331-338. https://doi.org/10.1016/j.ijpharm.2011.06.030
피인용 문헌
- The effects of curcumin on musculoskeletal pain: a systematic review protocol vol.13, pp.2, 2015, https://doi.org/10.11124/jbisrir-2015-1684
- Zingiberaceae extracts for pain: a systematic review and meta-analysis vol.14, pp.1, 2015, https://doi.org/10.1186/s12937-015-0038-8
- Curcumin in turmeric: Basic and clinical evidence for a potential role in analgesia vol.43, pp.4, 2018, https://doi.org/10.1111/jcpt.12703
- Effects of curcumin on ion channels and transporters vol.5, pp.None, 2012, https://doi.org/10.3389/fphys.2014.00094
- Synergistic effect of the interaction between curcumin and diclofenac on the formalin test in rats vol.21, pp.12, 2012, https://doi.org/10.1016/j.phymed.2014.06.015
- Anti-allodynic effect induced by curcumin in neuropathic rat is mediated through the NO-cyclic-GMP-ATP sensitive K + channels pathway vol.20, pp.None, 2012, https://doi.org/10.1186/s12906-020-2867-z
- A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents vol.35, pp.12, 2012, https://doi.org/10.1002/ptr.7224